{ "case_number": "CAC-UDRP-107311", "time_of_filling": "2025-02-14 09:57:22", "domain_names": [ "novartissingaporepteltd.com" ], "case_administrator": "Olga Dvořáková (Case admin)", "complainant": [ "Novartis AG" ], "complainant_representative": "Abion GmbH", "respondent": [ "sriniwas M (growth your business)" ], "respondent_representative": null, "factual_background": "

I. Complainant<\/strong><\/span><\/p>\n

\n

The Complainant is one of the biggest global pharmaceutical and healthcare groups. Novartis AG (the “Complainant”), created in 1996 through a merger of two other companies Ciba-Geigy and Sandoz, is the holding company of the Novartis Group.<\/span><\/p>\n

According to the Complainant's submissions, the Novartis company owns a subsidiary in Singapore where the Respondent is based.  <\/span>
<\/span><\/p>\n

Moreover, previous UDRP panels have stated that the NOVARTIS trademark is well-known (see Novartis AG v. Amartya Sinha, Global Webs Link, Novartis RO, WIPO Case No. D2020-3203). <\/span> <\/span><\/p>\n

The Complainant is also very active via its official social media platforms.<\/span><\/p>\n


II. The disputed domain name and the Respondent<\/strong><\/span>

<\/p>\n

<novartissingaporepteltd.com> was registered on January 11, 2025 and currently links to a PPC webpage. According to the information provided by the Registrar, the Respondent is growing your business (Organization), sriniwas (name), M (last name).<\/p>\n<\/div>", "other_legal_proceedings": "

The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>", "no_response_filed": "

COMPLAINANT<\/strong><\/span><\/p>\n

\n


The Complainant supports that the disputed domain name is confusingly similar to its trademarks as it entirely incorporates the NOVARTIS trademark. The addition of generic\/geographic elements does not exclude the confusing similarity between the Complainant NOVARTIS trademarks and the disputed domain name. The addition of the gTLD “.com” does not add any distinctiveness to the disputed domain name.<\/span>

The Complainant denies that the Respondent has rights or legitimate interests in respect of the disputed domain name and Novartis AG has never had any business relationship with the Respondent. Moreover, the Complainant excludes that the Respondent is known with the disputed domain name.<\/span>

The Complainant supports that the disputed domain name is registered and used in bad faith, given the high reputation of the NOVARTIS trademark and the fact that <<\/span>novartissingaporepteltd.com> is used in connection with PPC links.<\/p>\n

RESPONDENT<\/strong><\/span><\/p>\n

No administratively compliant Response has been filed.<\/p>\n<\/div>", "rights": "

The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>", "no_rights_or_legitimate_interests": "

The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>", "bad_faith": "

The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>", "procedural_factors": "

The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>", "decision": "Accepted", "panelists": [ "Andrea Mascetti" ], "date_of_panel_decision": "2025-03-16 00:00:00", "informal_english_translation": "

The Complainant proved to be the owner of the following trademark registrations:<\/p>\n

International Trademark reg. no. 1349878, designating India and Singapore for NOVARTIS, of November 29, 2016;<\/p>\n

International trademark reg. no. 1544148, designating Singapore for NOVARTIS®, of June 29, 2020;<\/p>\n

US trademark reg. no. 4986124 for NOVARTIS®of June 28, 2016;<\/p>\n

US trademark reg. no. 6990442 for NOVARTIS® of February 28, 2023;<\/p>\n

EU trademark reg. no. 304857 for NOVARTIS® of June 25, 1999;<\/p>\n

Singapore Trademark reg. no. 40201711477Y for NOVARTIS of November 29, 2016;<\/p>\n

Singapore Trademark reg. no. T9607248G for NOVARTIS® of February 15, 1996.<\/p>", "decision_domains": { "novartissingaporepteltd.com": "TRANSFERRED" }, "panelist": null, "panellists_text": null }